What sector does Cigna belong to?

Cigna operates in the Health Care sector, specifically the Health Care Services industry, and is listed on the US markets.

What is the current share price of CI?

As of the latest available quote, CI traded at $280.76. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of CI?

Cigna has a price-to-earnings (P/E) ratio of about 11.62. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of CI?

The market capitalisation of Cigna is approximately $75.41B.

For its latest reported financial year, Cigna recorded a net profit margin of about 2.17%.

Does CI pay a dividend?

Cigna currently has a dividend yield of about 2.19%.

What is the return on equity (ROE) of CI?

Cigna has a return on equity (ROE) of about 13.98%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of CI?

Over the past 52 weeks, CI has traded between a low of $239.51 and a high of $315.47.

Cigna

CI US Health Care Health Care Services

S&P 500

$280.76

-0.05%

Delayed · cached 15 min

Fair value analysis

Cigna

$280.76

Close used for this calculation

$446.03Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

61/100

Profitability13/25

Returns16/25

Balance Sheet14/25

Efficiency18/25

Growth17/25

Good

Quality radar

Consensus fair value

$446.03

Below FV

▲ +58.9% against the close used

Model range $283.77 – $743.04

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$283.77Fair value$446.03Bull$743.04

FairClose

52-week traded range

52W low $244.4152W high $311.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Cigna closed at $280.76, 37.1% below the consensus fair value of $446.03 drawn from 9 valuation models.

Financial DNA score 61/100 — Good. P/E of 12.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$440.25

+56.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

$283.77

+1.1%

√(22.5 × EPS × BVPS)

EPS=22.18, BVPS=161.36

P/E Fair Value

$443.60

+58.0%

EPS × 20x (sector P/E)

EPS=22.18, Sector P/E=20x

Peter Lynch (PEG)

$295.66

+5.3%

EPS × Growth% (PEG = 1 is fair)

EPS=22.18, g=13.3%

EV/EBITDA

$743.04

+164.7%

(EBITDA × 16.7x − Net Debt) ÷ Shares

EBITDA=11.98B

Dividend Discount (DDM)

$325.96

+16.1%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=6.04, r=10%, g=8%

Book Value (P/B)

$321.91

+14.7%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=161.36, ROE=14%, g=6%, r=10%

Reverse DCF

$280.76

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 0.9% | Historical: 13.3%

Margin of Safety

$291.91

+4.0%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=389.21, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer